Buscar recursos académicos

Background: Risk stratification is a cornerstone of cardiovascular disease (CVD) prevention and a main strategy proposed to achieve global goals of reducing premature CVD deaths. There are no cardiovascular risk scores b...

Background This meta-analysis systematically evaluated the impact of intensive (typically targeting systolic BP [SBP]

Abstract Introduction We conducted a network meta-analysis of randomized trials to assess the effect of different exercises on the renal and cardiovascular function of patients with chronic kidney disease not receiving d...

Background: Endothelial dysfunction (ED) is a key pathophysiological mechanism in cardiovascular diseases (CVD). The Endothelial Activation and Stress Index (EASIX), derived from routine laboratory markers, has been prop...

Existen crecientes informes sobre una drástica caída en consultas y realización de procedimientoscardiovasculares (incluyendo urgencias y emergencias) en regiones afectadas por la pandemia deCOVID-19, con el consecuen...

Abstract Background Low- and middle-income countries are facing an increasing burden of disability and death due to cardiovascular diseases. Policy makers and healthcare providers alike need resource estimation tools to ...

Cardiovascular diseases remain the leading cause of mortality worldwide, making accurate and efficient imaging-based diagnosis indispensable. Modern modalities such as Coronary Computed Tomography Angiography, Cardiac Ma...

Abstract Background Cardiovascular diseases (CVDs) continue to be the leading cause of mortality worldwide, accounting for approximately 19.8 million deaths in 2022, with ischemic heart disease and stroke responsible for...

Abstract Carpal tunnel syndrome (CTS) is linked to cardiovascular outcomes such as cardiac amyloidosis, but prior studies with limited scope leave uncertainty about its role as an marker of other major cardiovascular dis...

Background: Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus. Understanding diabetes patients' knowledge and perception of CVD risk factors is es...

Introduction and Aims: Evidence suggests a relationship between oral microbiota and cardiovascular diseases (CVDs). However, the roles of specific microbiota in the pathogenesis of CVDs remain underexplored. Methods: Two...

Abstract Background Cardiovascular diseases (CVD) are a major global health problem, causing 17.9 million deaths in 2019, with 85% due to myocardial infarction and stroke. This study explores psychological and behaviour...

Objective: To examine the associations of phenotypic age acceleration (PAA) with all-cause and cardiovascular mortality among U.S. adults at risk for heart failure. Methods: We analyzed 19,665 participants aged ≥20 ye...

Phα1β, a peptide toxin purified from Phoneutria nigriventer spider venom, has a dual antinociceptive effect, inhibiting high-voltage-activated calcium channels and antagonising the TRPA1 receptor that differentiates it...

Study objective: Systemic inflammation increases the risk of cardiovascular events and is often present in patients with atherosclerotic cardiovascular disease (ASCVD), particularly in those who also have chronic kidney ...

Abstract Background Left atrioventricular coupling index (LACI) has been recognized for its prognostic significance across various cardiovascular diseases; however, its role in non-ischemic dilated cardiomyopathy (NIDCM)...

Psoriasis is a chronic inflammatory skin disease associated with increased proliferation of the epidermis. Combination of genetic, immunological and environmental factors underlies the skin lesion. Until recently, psoria...

Background Although psychological stress has emerged as an important determinant of cardiovascular disease (CVD) risk, it remains excluded from the recently updated cardiovascular health (CVH) metrics, known as Life’s ...

We read with great interest the recent article by Park H et al (1), entitled “Association between job insecurity and cardiovascular disease among workers with type 2 diabetes mellitus”. The study provides important e...

OBJECTIVE: Vascular calcifications and chronic inflammation are the main reasons of the decreased life span and prevalent morbidity for patients on renal replacement therapy due to chronic renal failure. Scoring systems ...

OBJECTIVE: The leading cause of death in patients with end-stage renal disease (ESRD) is cardiovascular disease. Prohepcidin, which is the precursor of hepcidin is a peptide hormone produced by the liver, and appears to ...

Patients with end-stage-renal disease (ESRD) experience a high cardiovascular mortality and cardiovascular risk factors such as obesity, hyperlipidemia and hypertension are very common. Recent epidemiological research ha...

Oxidative stress (OS), derived from an imbalance between reactive oxygen species (ROS) accumulation and impaired antioxidant defense, is a recognized cause of atherothrombosis, through a complex interaction between low-g...

Objective: Chronic kidney disease (CKD) is associated with increased mortality and high cardiovascular (CV) risk. Slow heart rate recovery (HRR) is an index of cardiac autonomic dysfunction and also a prognostic tool for...